Cargando…

New Therapeutic Horizons for Graves’ Hyperthyroidism

Graves’ hyperthyroidism is characterized by the presence of autoantibodies that stimulate the thyroid-stimulating hormone receptor (TSHR), resulting in uncontrolled secretion of excessive thyroid hormone. Conventional treatments, including antithyroid medication, radioiodine, or surgery have remaine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lane, Laura C, Cheetham, Tim D, Perros, Petros, Pearce, Simon H S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567404/ https://www.ncbi.nlm.nih.gov/pubmed/32845332 http://dx.doi.org/10.1210/endrev/bnaa022

Ejemplares similares

New Therapeutic Horizon of Graves’ Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine
por: He, Qiongyao, et al.
Publicado: (2022)

Graves’ disease: moving forwards
por: Lane, Laura C, et al.
Publicado: (2023)

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
por: Pearce, Simon H.S., et al.
Publicado: (2019)

Asymmetric Graves’ Orbitopathy
por: Panagiotou, Grigorios, et al.
Publicado: (2020)

Graves’ hyperthyroidism in pregnancy: a clinical review
por: Nguyen, Caroline T., et al.
Publicado: (2018)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
por: Abdi, Hengameh, et al.
Publicado: (2020)

Hyperthyroidism and Graves’ disease: Is an ultrasound examination needed?
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2016)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Central hyperthyroidism combined with Graves' disease: case series and review of the literature
por: Mo, Caiyan, et al.
Publicado: (2023)

Adjuvant rituximab, a potential treatment for the young patient with Graves’ hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial
por: Cole, Michael, et al.
Publicado: (2019)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

Hyperthyroidism Due to Graves Disease After Radiofrequency Ablation
por: McAninch, Elizabeth A, et al.
Publicado: (2023)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

A Review of Testing for Distinguishing Hashimoto’s Thyroiditis in the Hyperthyroid Stage and Grave’s Disease
por: Liu, Yutong, et al.
Publicado: (2023)

COVID-19: a cause of recurrent Graves’ hyperthyroidism?
por: Jiménez-Blanco, S., et al.
Publicado: (2020)

Pancytopenia with cellular bone marrow related to Graves’ hyperthyroidism
por: Raina, Sujeet, et al.
Publicado: (2012)

A patient-specific treatment model for Graves’ hyperthyroidism
por: Pandiyan, Balamurugan, et al.
Publicado: (2018)

Unilateral gynecomastia as an initial presentation of hyperthyroid Graves’ disease
por: Sakulterdkiat, Titipatima, et al.
Publicado: (2021)

Urticarial vasculitis in a young woman with Graves hyperthyroidism
por: Hung, Yi-Teng, et al.
Publicado: (2022)

AZD-1222: Aggravation of Graves hyperthyroidism: case report
Publicado: (2022)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

Thyroid Function after Subtotal Thyroidectomy in Patients with Graves' Hyperthyroidism
por: Limonard, E. J., et al.
Publicado: (2012)

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

Tozinameran: Recurrence of hyperthyroidism secondary to Graves' disease: case report
Publicado: (2021)

Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism
por: Weng, Huan, et al.
Publicado: (2023)

SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease
por: Murugan, Avaniyapuram Kannan, et al.
Publicado: (2021)

Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement
por: Bartalena, L., et al.
Publicado: (2015)

Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model
por: Schlüter, Anke, et al.
Publicado: (2018)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Persistent hyperthyroidism and de novo Graves’ ophthalmopathy after total thyroidectomy
por: Tay, Wei Lin, et al.
Publicado: (2017)

SARS-CoV-2 vaccination related hyperthyroidism of Graves’ disease
por: Shih, Shyang-Rong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9eqbjgk1opc0jrbpafkhqt7ao